IGF-1R ellenanyag-drog konjugátum és alkalmazása rák kezelésében

• 收藏
• 分享

专利权人:

Pierre Fabre Medicament

发明人:

RILATT, Ian,PEREZ, Michel,GOETSCH, Liliane,BROUSSAS, Matthieu,BEAU-LARVOR, Charlotte,HAEUW, Jean-François,CHAMPION, Thierry,ROBERT, Alain

申请号：

HUE15720045

公开号：

HUE044862T2

申请日:

2015.04.27

申请国别(地区):

HU

年份:

2019

代理人:

摘要：

The present invention relates to an antibody-drug-conjugate capable of binding IGF-1R. From one aspect, the invention relates to an antibody-drug-conjugate comprising an antibody capable of binding to IGF-1R, said antibody being conjugated to at least one drug selected from derivatives of dolastatin 10 and auristatins. The invention also comprises method of treatment and the use of said antibody-drug-conjugate for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/